ProClinica was founded on a diagnostic
imaging account, because its founder, Mel Snyder, developed the first CME program on a nuclear medicine agent, Procter &
Gamble's Osteoscan, while he was a marketing manager at Medcom.
ProClinica's first imaging account was New England Nuclear, which hired the agency to
promote gallium-67 tumor imaging, and then programs on lung, liver, brain, kidney, bone, and -- most important -- cardiac
imaging with Thallium-201.
ProClinica launched SPECTAmine brain imaging for Roche Medi+Physics and Ceretec
brain imaging for Amersham. It launched a gantry-type SPECT brain imaging system and a gadolinium bone densitometry for Novo,
and a specialized thyroid imaging system for M&SE. And it developed a series of educational pieces for Toshiba CT systems.
As vice president of marketing at Immunomedics, ProClinica founder Mel Snyder re-launched
CEA-Scan antibody-fragment tumor imaging, and developed the promotional materials used for the infection-targeting agent LeukoScan,
in Europe.
In short -- ProClinica knows imaging.
